(IGMS) IGM Biosciences - Performance -87.2% in 12m
Compare IGMS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-85.05%
#150 in Group
Rel. Strength
2.06%
#7793 in Universe
Total Return 12m
-87.16%
#183 in Group
Total Return 5y
-97.95%
#165 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: IGMS (-87.2%) vs XBI (-11.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
9.32% | 17.6% | 174% | 12.4 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.15% | 32% | 48.9% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-6.52% | -8.21% | 34.6% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
8.27% | 11.5% | 33.2% | 65.7 | 36 | 1.31 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.35% | 22.3% | -1.74% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
26.9% | -11.6% | 7.86% | 39.2 | 23.6 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
8.6% | 26% | -5.07% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| ERF PA Eurofins Scientific SE |
14.1% | 0.03% | 8.57% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: IGMS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IGMS
| Total Return (including Dividends) | IGMS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.00% | 3.80% | 8.14% |
| 3 Months | -13.77% | -11.69% | -3.09% |
| 12 Months | -87.16% | -11.47% | 13.34% |
| 5 Years | -97.95% | -19.52% | 120.03% |
| Trend Score (consistency of price movement) | IGMS | XBI | S&P 500 |
| 1 Month | -26.2% | 48.1% | 90.1% |
| 3 Months | -45.8% | -81% | -66.3% |
| 12 Months | -64.9% | -54.5% | 48.9% |
| 5 Years | -88.9% | -53.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #82 | -3.66% | -7.53% |
| 3 Month | #71 | -2.36% | -11.0% |
| 12 Month | #184 | -85.5% | -88.7% |
| 5 Years | #167 | -97.5% | -99.1% |
FAQs
Does IGMS IGM Biosciences outperforms the market?
No,
over the last 12 months IGMS made -87.16%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.47%.
Over the last 3 months IGMS made -13.77%, while XBI made -11.69%.
Over the last 3 months IGMS made -13.77%, while XBI made -11.69%.
Performance Comparison IGMS vs Indeces and Sectors
IGMS vs. Indices IGMS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.2% | -8.14% | -87.8% | -101% |
| US NASDAQ 100 | QQQ | -12.3% | -11.0% | -88.8% | -102% |
| US Dow Jones Industrial 30 | DIA | -10.7% | -4.69% | -86.8% | -96.5% |
| German DAX 40 | DAX | -8.66% | -12.3% | -113% | -112% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.7% | -5.73% | -87.7% | -96.2% |
| Hongkong Hang Seng | HSI | -12.8% | -14.4% | -98.8% | -97.5% |
| India NIFTY 50 | INDA | -7.75% | -6.45% | -91.2% | -93.0% |
| Brasil Bovespa | EWZ | -10.7% | -9.92% | -93.4% | -80.7% |
IGMS vs. Sectors IGMS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.34% | -7.97% | -92.2% | -110% |
| Consumer Discretionary | XLY | -14.4% | -11.7% | -88.1% | -108% |
| Consumer Staples | XLP | -7.19% | 0.84% | -91.3% | -94.6% |
| Energy | XLE | -12.8% | -6.83% | -81.2% | -80.5% |
| Financial | XLF | -10.6% | -7.89% | -92.6% | -111% |
| Health Care | XLV | -6.17% | 1.86% | -82.7% | -83.5% |
| Industrial | XLI | -12.0% | -10.5% | -89.2% | -101% |
| Materials | XLB | -10.4% | -6.20% | -84.0% | -83.3% |
| Real Estate | XLRE | -7.20% | -4.70% | -88.1% | -101% |
| Technology | XLK | -13.4% | -13.8% | -86.3% | -98.2% |
| Utilities | XLU | -8.01% | -2.66% | -92.7% | -102% |
| Aerospace & Defense | XAR | -9.66% | -9.90% | -96.5% | -115% |
| Biotech | XBI | -3.88% | -3.80% | -68.6% | -75.7% |
| Homebuilder | XHB | -12.2% | -9.86% | -76.8% | -82.5% |
| Retail | XRT | -13.9% | -11.7% | -84.1% | -86.5% |